Latest stories
-
Past COVID Infection Gives 83% Protection for 5 Months, UK Study Finds
In a lecture delivered on March 25, 2020, via the MedCram YouTube channel, Dr. Roger Seheult examined whether individuals could be reinfected…
-
Takeda Begins Developing Plasma-Derived Antibody Therapy TAK-888 for COVID-19
On 5 March 2020, Takeda Pharmaceutical Company announced the launch of a new therapy, designated TAK‑888, that will use plasma from individuals…
-
Wuhan Lockdown Announced as Coronavirus Death Toll Reaches 17
On January 23, 2020, at 10 a.m. local time, Chinese authorities imposed a sweeping lockdown on Wuhan, a city of 11 million…
-
Bank of England Says Supplier Sold Early Audio of Press Conferences to Hedge Funds
The Bank of England’s press conference audio feed was hacked and accessed by high-speed traders minutes before its scheduled broadcast on December…
-
Bank of England’s James Talbot Says Climate Is Now Core Central Bank Business
The United Kingdom’s Financial Sector Faces Climate Reality The United Kingdom banking and insurance industries are confronting severe financial risks associated with…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992